INHIBRX BIOSCIENCES INC
INBX·45720N103·US·Common Stock·Healthcare - Biotechnology-13D/G
INBX (INHIBRX BIOSCIENCES INC) is held by 87 institutional investors as of Q1 2026. Largest holders: VIKING GLOBAL INVESTORS LP ($96.7M), MORGAN STANLEY ($84.9M), HighTower Advisors, LLC ($58.5M). Net institutional sentiment: Mixed.
87
Holders
(6 Elite)
$575.4M
Total Value
58% (86)
Consensus
50 buying - 36 selling
13F: Insider & Congress:
Who's Trading
ActivistPAPerceptive Advisors LLC10.0%May 15, 2026
InsiderVLVIKING GLOBAL INVESTORS LPSell $10.0MOct 7, 2025
InsiderVLVIKING GLOBAL INVESTORS LPSell $808KOct 7, 2025
InsiderVLVIKING GLOBAL INVESTORS LPSell $526KOct 7, 2025
Showing 1-20 of 95
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer